99% Savings - Buy Just @1 Rs X
Triohale Rotacap (20) is a prescription drug, available for use as Rotacaps. Other than this, Triohale Rotacap (20) has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Triohale Rotacap (20). The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Triohale Rotacap (20) as well, which are listed below. These side effects of Triohale Rotacap (20) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Triohale Rotacap (20) has a Severe effect for pregnant women and Severe effect on lactating mothers. It is important to know if Triohale Rotacap (20) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Triohale Rotacap (20) related warnings section.
Triohale Rotacap (20) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Angioedema are examples of such conditions. The section on Triohale Rotacap (20) contraindications lists all such conditions.
Besides this, Triohale Rotacap (20) may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Triohale Rotacap (20) is safe while driving, and is is addictive in nature.
Triohale Rotacap (20) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Triohale Rotacap (20) safe for pregnant women?
Triohale can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Triohale Rotacap (20) safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Triohale. It should only be taken after medical advice.
What is the effect of Triohale Rotacap (20) on the Kidneys?
Triohale rarely harms the kidneys.
What is the effect of Triohale Rotacap (20) on the Liver?
There may be an adverse effect on the liver after taking Triohale. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Triohale Rotacap (20) on the Heart?
You may experience side effects on your heart after taking Triohale. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Triohale Rotacap (20) unless your doctor advises you to do so -
Is this Triohale Rotacap (20) habit forming or addictive?
No, there is no any evidence that Triohale Rotacap (20) is addictive.
Interaction between Food and Triohale Rotacap (20)
There is no information on the effects of taking Triohale Rotacap (20) with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Triohale Rotacap (20)
Consult your doctor before consuming alcohol while taking Triohale Rotacap (20) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alvesco® (ciclesonide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 359-360
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1207
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 117
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Spiriva® HandiHaler® (tiotropium bromide)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Braltus® (tiotropium bromide)